• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

保护患者和医疗保健实践免受医疗保险和医疗补助欺诈的建议。

Recommendations to protect patients and health care practices from Medicare and Medicaid fraud.

出版信息

J Am Pharm Assoc (2003). 2020 Nov-Dec;60(6):e60-e65. doi: 10.1016/j.japh.2020.05.011. Epub 2020 Jun 29.

DOI:10.1016/j.japh.2020.05.011
PMID:32616445
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7323645/
Abstract

Fraud is defined as knowingly submitting, or causing to be submitted, false claims or making misrepresentations of a fact to obtain a federal health care payment for which no entitlement would otherwise exist. In today's health care environment, Medicare and Medicaid fraud is not uncommon. The negative impact of fraud is vast because it diverts resources meant to care for patients in need to the benefit of fraudsters. Fraud increases the overall costs for vital health care services and can potentially be harmful to Medicare and Medicaid beneficiaries. The objectives of this commentary are to describe the types and trends of Medicare and Medicaid fraud that are committed, and provide recommendations to protect patients and health care practices. Specifically, this article identifies types of Medicare and Medicaid fraud at beneficiary (patient) and provider level, and it can be intentional or unintentional. This article also describes the 3 primary laws that prohibit fraud and gives fraud case examples relevant to each law, including the False Claims Act, Anti-Kickback Statute, and the Stark Law. We also discuss currently trending and emerging areas, including opioid and pharmacogenetic testing; both have experienced heavier and higher-profile instances of fraud in today's health care landscape. Last, the article summarizes detection methods and recommendations for health care providers and patients to protect themselves against fraud. Recommended strategies to combat fraud are discussed at policy, practice, and grassroots levels. Health care practitioners, including pharmacists, can use these strategies to protect themselves and their patients from becoming victims of fraud or unknowingly committing fraud.

摘要

欺诈被定义为故意提交或导致提交虚假索赔或虚假陈述事实,以获取本不应存在的联邦医疗保健付款。在当今的医疗保健环境中,医疗保险和医疗补助欺诈并不罕见。欺诈的负面影响是巨大的,因为它将原本用于照顾有需要的患者的资源转移到了欺诈者的利益上。欺诈增加了重要医疗保健服务的总成本,并可能对医疗保险和医疗补助的受益人造成伤害。本评论的目的是描述医疗保险和医疗补助欺诈的类型和趋势,并为保护患者和医疗保健实践提供建议。具体来说,本文确定了在受益人和医疗服务提供者层面发生的医疗保险和医疗补助欺诈的类型,这些欺诈可能是故意的,也可能是非故意的。本文还描述了禁止欺诈的 3 项主要法律,并给出了与每项法律相关的欺诈案例,包括《虚假索赔法》《反回扣法规》和《斯塔克法》。我们还讨论了当前流行和新兴的领域,包括阿片类药物和药物遗传学检测;在当今的医疗保健领域,这两个领域都经历了更多和更高调的欺诈事件。最后,本文总结了检测方法和建议,供医疗保健提供者和患者保护自己免受欺诈。在政策、实践和基层层面讨论了打击欺诈的建议策略。医疗保健从业者,包括药剂师,可以使用这些策略来保护自己和患者免受欺诈或不知情的欺诈。

相似文献

1
Recommendations to protect patients and health care practices from Medicare and Medicaid fraud.保护患者和医疗保健实践免受医疗保险和医疗补助欺诈的建议。
J Am Pharm Assoc (2003). 2020 Nov-Dec;60(6):e60-e65. doi: 10.1016/j.japh.2020.05.011. Epub 2020 Jun 29.
2
Kickbacks, self-referrals, and false claims: the hazy boundaries of health-care fraud.回扣、自我推荐和虚假索赔:医疗保健欺诈的模糊界限。
Chest. 2013 Sep;144(3):1045-1050. doi: 10.1378/chest.12-2889.
3
False Claims Act and Anti-Kickback Statute: Avoiding Legal Landmines.《虚假申报法案》和《反回扣法规》:避免法律雷区。
Neurol Clin. 2023 Aug;41(3):523-531. doi: 10.1016/j.ncl.2023.03.006. Epub 2023 May 20.
4
Medicare and State Health Care Programs: Fraud and Abuse; Revisions to the Safe Harbors Under the Anti-Kickback Statute and Civil Monetary Penalty Rules Regarding Beneficiary Inducements. Final rule.医疗保险和州医疗保健计划:欺诈与滥用;《反回扣法》安全港条款及关于受益人诱导的民事罚款规则的修订。最终规则。
Fed Regist. 2016 Dec 7;81(235):88368-409.
5
Pharmacy waste, fraud, and abuse in health care reform.医药废物、医疗改革中的欺诈与滥用。
J Am Pharm Assoc (2003). 2011 Mar-Apr;51(2):e3-16. doi: 10.1331/JAPhA.2011.10168.
6
Health care fraud: recent developments and timeless advice.医疗保健欺诈:最新进展与永恒建议。
Tex Med. 2003 Oct;99(10):50-6.
7
Publication of OIG Special Fraud Alerts: home health fraud, and fraud and abuse in the provision of medical supplies to nursing facilities--HHS. Notice.美国卫生与公众服务部监察长办公室特别欺诈警报发布:家庭健康欺诈以及向护理机构提供医疗用品过程中的欺诈与滥用行为——通知。
Fed Regist. 1995 Aug 10;60(154):40847-51.
8
Medicare and State health care programs: fraud and abuse; OIG anti-kickback provisions--HHS. Final rule.医疗保险和州医疗保健计划:欺诈与滥用;监察长办公室的反回扣规定——美国卫生与公众服务部。最终规则。
Fed Regist. 1991 Jul 29;56(145):35952-87.
9
The false claims act and the eroding scienter in healthcare fraud litigation.《虚假索赔法》与医疗保健欺诈诉讼中逐渐削弱的明知故犯原则
Ann Health Law. 2011 Winter;20(1):49-76, 8 p preceding 1.
10
The Stark truth: what your physician clients should know about Stark Law and the Anti-Kickback Statute.严峻的事实:你的医生客户应该了解的斯塔克法案和反回扣法规。
J Health Care Finance. 2013 Spring;39(3):85-92.

引用本文的文献

1
MIPS Under Scrutiny: Exploring the Association Between Providers With Fraudulent Practices and Quality Metrics Within MACRA's Framework.MIPS 受到审查:在 MACRA 框架内探索存在欺诈行为的医疗服务提供者与质量指标之间的关联。
J Eval Clin Pract. 2025 Aug;31(5):e70217. doi: 10.1111/jep.70217.
2
Disparities in Medicaid and Medicare physician reimbursements for ophthalmic procedures.医疗补助计划(Medicaid)和医疗保险(Medicare)在眼科手术医生报销方面存在的差异。
PLoS One. 2025 Jun 18;20(6):e0324383. doi: 10.1371/journal.pone.0324383. eCollection 2025.
3
Perception of Enrollee Health Insurance Fraud among Healthcare Workers at a Tertiary Hospital in Kaduna State, North-western Nigeria.尼日利亚西北部卡杜纳州一家三级医院医护人员对参保人医疗保险欺诈行为的认知
Niger Med J. 2025 Apr 3;66(1):256-265. doi: 10.71480/nmj.v66i1.700. eCollection 2025 Jan-Feb.
4
A global scoping review on the patterns of medical fraud and abuse: integrating data-driven detection, prevention, and legal responses.关于医疗欺诈和滥用模式的全球范围综述:整合数据驱动的检测、预防及法律应对措施
Arch Public Health. 2025 Feb 17;83(1):43. doi: 10.1186/s13690-025-01512-8.
5
Promoting appropriate medication use by leveraging medical big data.通过利用医学大数据促进合理用药。
Front Digit Health. 2024 Nov 7;6:1198904. doi: 10.3389/fdgth.2024.1198904. eCollection 2024.
6
Fraud Claims Filed Involving Practicing Ophthalmologists from 1985 Through 2020.1985年至2020年期间针对执业眼科医生的欺诈指控
Clin Ophthalmol. 2023 Jan 24;17:341-350. doi: 10.2147/OPTH.S397014. eCollection 2023.

本文引用的文献

1
Machine learning and the future of Medicare fraud detection.机器学习与医疗保险欺诈检测的未来。
J Am Acad Dermatol. 2020 Aug;83(2):e133. doi: 10.1016/j.jaad.2020.03.059. Epub 2020 Mar 29.
2
Association Between Treatment by Fraud and Abuse Perpetrators and Health Outcomes Among Medicare Beneficiaries.欺诈和滥用药行为者的治疗与医疗保险受益人健康结果之间的关联。
JAMA Intern Med. 2020 Jan 1;180(1):62-69. doi: 10.1001/jamainternmed.2019.4771.
3
Processes and barriers to implementation of point-of-care genotype-guided dosing of warfarin into UK outpatient anticoagulation clinics.在英国门诊抗凝诊所实施即时护理基因指导的华法林剂量调整的过程与障碍
Pharmacogenomics. 2019 Jun;20(8):599-608. doi: 10.2217/pgs-2019-0021. Epub 2019 May 3.
4
Strategies for Fighting Medicare Fraud.打击医疗保险欺诈的策略。
Health Care Manag (Frederick). 2018 Apr/Jun;37(2):147-154. doi: 10.1097/HCM.0000000000000204.
5
CDC Guideline for Prescribing Opioids for Chronic Pain--United States, 2016.美国 2016 年慢性疼痛阿片类药物处方指南。
JAMA. 2016 Apr 19;315(15):1624-45. doi: 10.1001/jama.2016.1464.
6
Challenges to integrating pharmacogenetic testing into medication therapy management.将药物遗传学检测整合到药物治疗管理中的挑战。
J Manag Care Spec Pharm. 2015 Apr;21(4):346-52. doi: 10.18553/jmcp.2015.21.4.346.
7
Medicare fraud in the United States: can it ever be stopped?美国的医疗保险欺诈:它能被杜绝吗?
Health Care Manag (Frederick). 2014 Jul-Sep;33(3):254-60. doi: 10.1097/HCM.0000000000000019.
8
Reductions in prescription opioid diversion following recent legislative interventions in Florida.佛罗里达州近期立法干预后处方阿片类药物转移的减少情况。
Pharmacoepidemiol Drug Saf. 2014 Mar;23(3):314-20. doi: 10.1002/pds.3553.
9
Drug take back in Hawai'i: partnership between the University of Hawai'i Hilo College of Pharmacy and the Narcotics Enforcement Division.夏威夷的药品回收:夏威夷大学希洛药学院与麻醉品执法部门之间的合作关系。
Hawaii J Med Public Health. 2014 Jan;73(1):26-31.
10
Kickbacks, self-referrals, and false claims: the hazy boundaries of health-care fraud.回扣、自我推荐和虚假索赔:医疗保健欺诈的模糊界限。
Chest. 2013 Sep;144(3):1045-1050. doi: 10.1378/chest.12-2889.